Kernal Biologics
KernalBio is a developer of mRNA therapies designed to develop curative immunotherapies for cancers and COVID-19. The company’s platform decreases immunogenicity of existing mRNA technologies and enables cell-specific therapeutic protein expression, thereby providing clinicians with more efficacious, tolerable, and affordable medicine for the global market.
